Evaluation of Mutations in Exons 7 and 8 of TP53 Gene in Breast Cancer Patients from Azarbaijan

BACKGROUND AND OBJECTIVE: Breast cancer is the most common type of malignancy in women, and TP53 tumor-suppressor gene is one of the most commonly transformed genes in human cancers. Accurate assessment of TP53 gene mutations in cancer patients can play an important role in diagnosis, prognosis, or...

Full description

Bibliographic Details
Main Authors: N Pouladi, MA Hosseinpour feizi, H Khani
Format: Article
Language:English
Published: Babol University of Medical Sciences 2016-02-01
Series:Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul
Subjects:
Online Access:http://jbums.org/browse.php?a_code=A-10-1062-1&slc_lang=en&sid=1
_version_ 1818557432839798784
author N Pouladi
MA Hosseinpour feizi
H Khani
author_facet N Pouladi
MA Hosseinpour feizi
H Khani
author_sort N Pouladi
collection DOAJ
description BACKGROUND AND OBJECTIVE: Breast cancer is the most common type of malignancy in women, and TP53 tumor-suppressor gene is one of the most commonly transformed genes in human cancers. Accurate assessment of TP53 gene mutations in cancer patients can play an important role in diagnosis, prognosis, or treatment. This study aimed to identify mutations of this gene in breast cancer patients. METHODS: In this descriptive study, 102 tumor samples were obtained from female breast cancer patients from Azarbaijan, Iran. All the participants were referred to hospitals of Tabriz during 2007-2009, and their DNA was extracted by Proteinase K. TP53 gene mutations in exons 7 and 8 and intron 7 were investigated using polymerase chain reaction technique and direct sequencing. FINDINGS: Seven (6.86%) cases of mutation and 14 (13.72%) cases of polymorphisms were identified. Mutations (CGG → CAG) at codon 248 (in two cases) and (CTG → CCG) at codon 257 in exon 7 and G>T mutation in the first nucleotide of intron 7 were observed. In exon 8, GTG>ATG mutation at codon 272, CCT>TCT mutation at codon 278, and three nucleotide deletion at codon 262 were identified. CONCLUSION: The results of this study showed a different pattern of TP53 gene mutation in female breast cancer patients. Further studies could specify the role of TP53 mutations in the progression of breast cancer
first_indexed 2024-12-13T23:59:25Z
format Article
id doaj.art-d72a215ee347462088626477dfb30635
institution Directory Open Access Journal
issn 1561-4107
2251-7170
language English
last_indexed 2024-12-13T23:59:25Z
publishDate 2016-02-01
publisher Babol University of Medical Sciences
record_format Article
series Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul
spelling doaj.art-d72a215ee347462088626477dfb306352022-12-21T23:26:25ZengBabol University of Medical SciencesMajallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul1561-41072251-71702016-02-011821925Evaluation of Mutations in Exons 7 and 8 of TP53 Gene in Breast Cancer Patients from AzarbaijanN Pouladi0MA Hosseinpour feizi1H Khani2 BACKGROUND AND OBJECTIVE: Breast cancer is the most common type of malignancy in women, and TP53 tumor-suppressor gene is one of the most commonly transformed genes in human cancers. Accurate assessment of TP53 gene mutations in cancer patients can play an important role in diagnosis, prognosis, or treatment. This study aimed to identify mutations of this gene in breast cancer patients. METHODS: In this descriptive study, 102 tumor samples were obtained from female breast cancer patients from Azarbaijan, Iran. All the participants were referred to hospitals of Tabriz during 2007-2009, and their DNA was extracted by Proteinase K. TP53 gene mutations in exons 7 and 8 and intron 7 were investigated using polymerase chain reaction technique and direct sequencing. FINDINGS: Seven (6.86%) cases of mutation and 14 (13.72%) cases of polymorphisms were identified. Mutations (CGG → CAG) at codon 248 (in two cases) and (CTG → CCG) at codon 257 in exon 7 and G>T mutation in the first nucleotide of intron 7 were observed. In exon 8, GTG>ATG mutation at codon 272, CCT>TCT mutation at codon 278, and three nucleotide deletion at codon 262 were identified. CONCLUSION: The results of this study showed a different pattern of TP53 gene mutation in female breast cancer patients. Further studies could specify the role of TP53 mutations in the progression of breast cancerhttp://jbums.org/browse.php?a_code=A-10-1062-1&slc_lang=en&sid=1Breast cancerMutationTP53 gene
spellingShingle N Pouladi
MA Hosseinpour feizi
H Khani
Evaluation of Mutations in Exons 7 and 8 of TP53 Gene in Breast Cancer Patients from Azarbaijan
Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul
Breast cancer
Mutation
TP53 gene
title Evaluation of Mutations in Exons 7 and 8 of TP53 Gene in Breast Cancer Patients from Azarbaijan
title_full Evaluation of Mutations in Exons 7 and 8 of TP53 Gene in Breast Cancer Patients from Azarbaijan
title_fullStr Evaluation of Mutations in Exons 7 and 8 of TP53 Gene in Breast Cancer Patients from Azarbaijan
title_full_unstemmed Evaluation of Mutations in Exons 7 and 8 of TP53 Gene in Breast Cancer Patients from Azarbaijan
title_short Evaluation of Mutations in Exons 7 and 8 of TP53 Gene in Breast Cancer Patients from Azarbaijan
title_sort evaluation of mutations in exons 7 and 8 of tp53 gene in breast cancer patients from azarbaijan
topic Breast cancer
Mutation
TP53 gene
url http://jbums.org/browse.php?a_code=A-10-1062-1&slc_lang=en&sid=1
work_keys_str_mv AT npouladi evaluationofmutationsinexons7and8oftp53geneinbreastcancerpatientsfromazarbaijan
AT mahosseinpourfeizi evaluationofmutationsinexons7and8oftp53geneinbreastcancerpatientsfromazarbaijan
AT hkhani evaluationofmutationsinexons7and8oftp53geneinbreastcancerpatientsfromazarbaijan